Omeprazole Tablet, Delayed Release
Product Images NDC 83324-141

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Omeprazole (NDC 83324-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Marketing Association Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Cdma Qc Omeprazole Dr Tablets 14ct Bottle Lbl)

Omeprazole 20 mg Delayed-Release Tablets label from Chain Drug Marketing Association INC. The label highlights the product as an acid reducer for frequent heartburn relief in a box containing 14 tablets for a one 14-day course of treatment. The label displays drug facts, active ingredient, usage directions, warnings, and manufacturer information. It emphasizes safety features and proper use instructions.*

FDA Label Image

Carton (Cdma Qc Omeprazole Dr Tablets 14ct Carton Label)

Omeprazole Delayed-Release Tablets, 20 mg oral tablets shown in a flattened carton label. The label indicates this product treats frequent heartburn and acid reduction with 14 tablets per bottle, providing a one 14-day course of treatment. Manufactured for Chain Drug Marketing Association INC, the label includes Drug Facts, directions, warnings, inactive ingredients, safety features, barcodes, and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.